Hepatitis Case Tossed

SAN FRANCISCO – A federal judge dismissed an amended class action Thursday accusing Blue Shield Life & Health of refusing to cover the breakthrough hepatitis C drug Harvoni, because Blue Shield has changed its policy to allow it.